4 completed, 1 active not recruiting, 1 recruiting, 1 suspended. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 4, Active not recruiting 1, Recruiting 1, Suspended 1, Unknown 1 |
| Phase 2 | 3 | Recruiting 1, Suspended 1, Unknown 1 |
Follow TS-1: new trials by email Literature Review of TS-1 trials Research Report on TS-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma hypofractionated radiotherapy, PD-1 inhibitor, TS-1 - Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy | Phase 1 / Phase 2 | Recruiting | West China Hospital | 84 | 2025-11-18 | 2026-01-06 |
| Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer. TBI-1401(HF10), Gemcitabine, Nab-paclitaxel - Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV | Phase 1 | Active not recruiting | Takara Bio Inc. | 36 | 2017-09-25 | 2024-12-09 |
| S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer OIS (Oxaliplatin, Irinotecan, S-1) - Gastrointestinal Neoplasms | Phase 1 | Completed | Hallym University Medical Center | 22 | 2012-06-01 | 2016-02-19 |
| SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer s1, Oxaliplatin - Gastric Cancer | Phase 1 / Phase 2 | Unknown | Chinese Academy of Medical Sciences | 71 | 2011-06-01 | 2016-06-14 |
| Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer Gemcitabine, S-1 - Biliary Tract Cancer | Phase 1 | Completed | Kansai Hepatobiliary Oncology Group | 6 | 2010-12-01 | 2014-10-23 |
| Sorafenib Plus S-1 in Advanced Solid Tumors Sorafenib, S-1 - Advanced Solid Tumors | Phase 1 | Completed | National Health Research Institutes, Taiwan | 30 | 2009-11-01 | 2015-10-19 |
| Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients Cediranib, Cisplatin, S-1 - Gastric Cancer | Phase 1 | Completed | AstraZeneca | 14 | 2009-08-01 | 2011-06-14 |
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. Taxotere, TS-1 - Gastric Cancer | Phase 1 / Phase 2 | Suspended | Hokkaido Gastrointestinal Cancer Study Group | 50 | 2005-04-01 | 2010-05-26 |
Stomach Neoplasms (3) · Biliary Tract Neoplasms (1) · Gastrointestinal Neoplasms (1) · Pancreatic Neoplasms (1)
AstraZeneca (1) · Chinese Academy of Medical Sciences (1) · Hallym University Medical Center (1) · Hokkaido Gastrointestinal Cancer Study Group (1) · Kansai Hepatobiliary Oncology Group (1) · National Health Research Institutes, Taiwan (1) · Takara Bio Inc. (1) · West China Hospital (1)
Japan (4) · China (2) · South Korea (1) · Taiwan (1)
Dae Young Zang, MD, PhD (1) · Hiroaki Nagano, MD, PhD (1) · Li-Tzong Chen, M.D., Ph.D. (1) · Lin Yang, MD (1) · Masahiro Asaka, MD, PhD (1) · Narikazu Boku, MD (1)